We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
168 hedge funds and large institutions have $3.58B invested in Alnylam Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 61 increasing their positions, 65 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
15% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 27
9% more capital invested
Capital invested by funds: $3.27B → $3.58B (+$308M)
2% more funds holding
Funds holding: 164 → 168 (+4)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
6% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 65
35% less call options, than puts
Call options by funds: $7.17M | Put options by funds: $11.1M
Holders
168
Holders Change
+4
Holders Change %
+2.44%
% of All Funds
4.88%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
31
Increased
61
Reduced
65
Closed
27
Calls
$7.17M
Puts
$11.1M
Net Calls
-$3.93M
Net Calls Change
-$8.69M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$363M |
| 2 |
AWG
Alpha Wave Global
New York
|
+$59.7M |
| 3 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$35.5M |
| 4 |
Morgan Stanley
New York
|
+$32.9M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$21.5M |
